972 filings
Page 5 of 49
8-K
ACER
Acer Therapeutics Inc.
8 Dec 22
Other Events
4:03pm
D
ACER
Acer Therapeutics Inc.
2 Dec 22
$1.50 mm in equity, sold $1.50 mm, 2 investors
8:09pm
SC 13D/A
ACER
Acer Therapeutics Inc.
2 Dec 22
Acer Therapeutics / Schelling Chris ownership change
4:02pm
4
ACER
Acer Therapeutics Inc.
1 Dec 22
Acer Therapeutics / Chris Schelling ownership change
4:02pm
4
ACER
Acer Therapeutics Inc.
1 Dec 22
Acer Therapeutics / STEVE ASELAGE ownership change
4:01pm
8-K
ACER
Acer Therapeutics Inc.
30 Nov 22
Acer Therapeutics Announces $1.5M Private Placement
8:35am
8-K
ACER
Acer Therapeutics Inc.
29 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
10-Q
2022 Q3
ACER
Acer Therapeutics Inc.
Quarterly report
14 Nov 22
5:23pm
8-K
ACER
Acer Therapeutics Inc.
14 Nov 22
Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update
5:09pm
8-K
ACER
Acer Therapeutics Inc.
14 Nov 22
Results of Operations and Financial Condition
4:55pm
8-K
ACER
Acer Therapeutics Inc.
26 Oct 22
Acer Therapeutics Receives Notice of Allowance of Key US Patent Application
9:01am
8-K
ACER
Acer Therapeutics Inc.
6 Oct 22
Other Events
9:00am
8-K
ACER
Acer Therapeutics Inc.
5 Oct 22
Acer Therapeutics Announces Expansion of ACER-801 (osanetant) Development Indications to Include Post-Traumatic Stress Disorder
9:01am
8-K
ACER
Acer Therapeutics Inc.
3 Oct 22
Other Events
9:00am
8-K
ACER
Acer Therapeutics Inc.
23 Aug 22
Regulation FD Disclosure
4:04pm
8-K
ACER
Acer Therapeutics Inc.
23 Aug 22
Entry into a Material Definitive Agreement
8:30am
10-Q
2022 Q2
ACER
Acer Therapeutics Inc.
Quarterly report
15 Aug 22
5:01pm
8-K
ACER
Acer Therapeutics Inc.
15 Aug 22
Acer Therapeutics Reports Q2 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
ACER
Acer Therapeutics Inc.
12 Aug 22
Orphan designation provides potential for up to 10-year market exclusivity in the EU upon regulatory approval
9:00am